Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 7/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14127758 | 1.00 | CHRM2 (0.37) | CHRM2CHRM1CHRM4CHRM3CHRM5 | |
| SCHEMBL12158777 | 0.93 | CHRM2 (0.37) | CHRM2CHRM1CHRM4CHRM3CHRM5 | |
| SCHEMBL12476221 | 0.89 | CHRM2 (0.42) | CHRM2CHRM1CHRM4CHRM3CHRM5 | |
| SCHEMBL177205 | 0.89 | — | — | |
| SCHEMBL6509410 | 0.88 | CHRM2 (0.32) | CHRM2CHRM1CHRM4CHRM3CHRM5 | |
| SCHEMBL6509408 | 0.88 | PLG (0.35) | CHRM2CHRM1CHRM4CHRM3CHRM5 | |
| Hydrochloric Acid SCHEMBL28064630 | 0.87 | — | — | |
| SCHEMBL27563919 | 0.87 | — | — | |
| SCHEMBL28780475 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL28770241 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117214314-B | Organic acid content detection box and detection method | 深圳爱湾智造科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117338661-A | Application of light peel papaya peel in preparation of cosmetics | 安康学院 | 2024-01-05 | — | — | CN | claimed |
| CN-117214314-A | Organic acid content detection box and detection method | 深圳爱湾智造科技有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-12606533-B2 | 3-phenylpropylamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20250353824-A1 | 3-PHENYLPROPYLAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250115608-A1 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | ARDELYX, INC. (US) | 2025-04-10 | — | — | US | disclosed |
| US-12209088-B2 | Hormone receptor modulators for treating metabolic conditions and disorders | ARDELYX, INC. (US) | 2025-01-28 | — | — | US | disclosed |
| WO-2024139171-A1 | IL-17A MODULATORS | USYNOVA PHARMACEUTICALS, LTD. (CN) | 2024-07-04 | — | — | WO | disclosed |
| CN-117214314-B | Organic acid content detection box and detection method | 深圳爱湾智造科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-111936468-B | Compounds with anticancer activity | 协和麒麟株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-117338661-A | Application of light peel papaya peel in preparation of cosmetics | 安康学院 | 2024-01-05 | — | — | CN | disclosed |
| WO-2000031049-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS AS PDGF-R AND/OR LCK TYROSINE KINASE INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| EP-1001946-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1998054157-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| EP-0371995-B1 | PROCESS FOR PRODUCING PHENYLHYDROQUINONES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1993-01-20 | — | — | EP | disclosed |
| EP-0371995-A1 | PROCESS FOR PRODUCING PHENYLHYDROQUINONES. | EASTMAN KODAK CO (US) | 1990-06-13 | — | — | EP | disclosed |
| US-4847429-A | ALKYLATION, ACID CATALYSTS, DEHYDROGENATION | EASTMAN KODAK COMPANY (US) | 1989-07-11 | — | — | US | disclosed |
| US-4816452-A | ANTIBIOTICS | BEECHAM GROUP P.L.C. (GB) | 1989-03-28 | — | — | US | disclosed |
| WO-1989000987-A1 | PROCESS FOR PRODUCING PHENYLHYDROQUINONES | EASTMAN KODAK COMPANY (US) | 1989-02-09 | — | — | WO | disclosed |
| EP-0210815-A2 | 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use | BEECHAM GROUP PLC (GB) | 1987-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353824-A1 | 3-PHENYLPROPYLAMINE DERIVATIVE | SF1, SF3A1, SFXN1 | CHRM2 1835/4885CHRM1 999/4885CHRM4 2553/4885 |
| US-12209088-B2 | Hormone receptor modulators for treating metabolic conditions and disorders | NR1H4, FXR1, GLP1R | CHRM2 514/4885CHRM1 350/4885CHRM4 803/4885 |
| US-12606533-B2 | 3-phenylpropylamine derivative | SF3A1, SF1, HTR1D | CHRM2 759/4885CHRM1 353/4885CHRM4 972/4885 |
| US-20250115608-A1 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | NR1H4, FXR1, GLP1R | CHRM2 514/4885CHRM1 350/4885CHRM4 803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.